Trump's threat of imposing a tariff on Denmark over desires to acquire Greenland has caught the attention of one of the ...

However, Novo Nordisk (NYSE: NVO), a pioneer in the field, remains one of the leaders. That likely won't change anytime soon, since the Denmark-based pharmaceutical giant has an excellent pipeline.

At Holdings Channel, we have reviewed the latest batch of the 22 most recent 13F filings for the 12/31/2024 reporting period, and noticed that Novo-Nordisk AS (Symbol: NVO) was held by 9 of these ...

Less-than-stellar phase 3 results with Novo Nordisk's highly anticipated obesity therapy CagriSema have caused its shares to fall by over a fifth, wiping around $94 billion off its market cap.

DURHAM, North Carolina -- The 263rd meeting between Duke and North Carolina was one-sided, an 87-70 Duke rout that felt twice as bad. Eleven miles and two realities separate the Blue Devils and ...

Novo Nordisk has agreed its second acquisition in the space of a month of a biotech in the obesity category, snapping up fellow Danish company Embark Biotech for €15 million (around $16 million ...

Bagsværd, Denmark, 27 January 2025 – On 11 November 2024, Novo Nordisk initiated a share repurchase ... to DKK 91.6 billion.Sales in North America Operations increased by 31% in Danish kroner ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Greenville-Pitt County Chamber of Commerce recognized Mark Phillips, vice president of statewide operations and executive ...